December 18, 2017 10:49 AM ET

Biotechnology

Company Overview of Zebra Biologics Inc.

Company Overview

Zebra Biologics Inc., a biopharmaceutical company, discovers and develops human antibodies and other biologic drugs for clinical needs across various disease areas. It develops platform technologies that allow cellular function-based screening for the discovery and selection of human therapeutic biologics (antibodies, peptides, and proteins) from DNA-encoded combinatorial libraries of human antibodies, peptides/protein-in-proteins. The company’s platform permits direct screening of antibody/peptide libraries in function-based assays for either agonists/antagonists of desired drug targets; allows direct screening for antibodies/peptides that induce morphogenic/phenotypic changes in primary cu...

1041 Old Marlboro Road

Concord, MA 01742

United States

Founded in 2013

Phone:

978-505-8719

Key Executives for Zebra Biologics Inc.

Chief Executive Officer
Age: 69
Compensation as of Fiscal Year 2017.

Zebra Biologics Inc. Key Developments

Zebra Biologics, Inc. Presents at Cambridge Healthtech Institute's 15th Annual Discovery on Target, Sep-26-2017 04:35 PM

Zebra Biologics, Inc. Presents at Cambridge Healthtech Institute's 15th Annual Discovery on Target, Sep-26-2017 04:35 PM. Venue: The Westin Copley Place, Boston, Massachusetts, United States. Speakers: Peter S. DiStefano, CSO.

Zebra Biologics Inc. to Collaborate with AbbVie to Discover New Antibody Therapeutics

Zebra Biologics Inc. announced that the company has entered into a collaboration with AbbVie to discover agonist antibody therapeutics for inflammatory diseases. Zebra will use its novel and patented function-based antibody discovery platform to generate antibodies that activate biological pathways associated with targets designated by AbbVie. Zebra and AbbVie will collaborate closely on the identification and pre-clinical evaluation of emerging candidates. Under the terms of the agreement, Zebra will lead the discovery of candidate agonist antibodies for designated targets and will collaborate with AbbVie in pre-clinical validation of select clinical candidates. Upon advancement of clinical candidates, AbbVie would be responsible for clinical development, manufacturing, regulatory approval and world-wide commercialization.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Zebra Biologics Inc., please visit www.zebrabiologics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.